Beacon Investment Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$178K Sell
356
-754
-68% -$362K 0.01% 264
2026
Q1
$546K Sell
1,110
-117
-10% -$63.5K 0.02% 175
2025
Q4
$711K Sell
1,227
-1,296
-51% -$733K 0.03% 150
2025
Q3
$1.22M Sell
2,523
-1,638
-39% -$762K 0.05% 123
2025
Q2
$1.69M Sell
4,161
-20,699
-83% -$8.65M 0.07% 114
2025
Q1
$12.4M Sell
24,860
-8,867
-26% -$4.8M 0.58% 54
2024
Q4
$17.5M Sell
33,727
-1,756
-5% -$965K 0.76% 48
2024
Q3
$21.9M Sell
35,483
-579
-2% -$343K 0.91% 41
2024
Q2
$19.9M Sell
36,062
-1,552
-4% -$889K 0.86% 41
2024
Q1
$21.9M Sell
37,614
-2,007
-5% -$1.13M 0.94% 36
2023
Q4
$21M Sell
39,621
-11,497
-22% -$5.56M 0.96% 35
2023
Q3
$25.9M Buy
51,118
+3,122
+7% +$1.66M 1.27% 26
2023
Q2
$25M Buy
47,996
+18,712
+64% +$10.1M 1.15% 27
2023
Q1
$16.9M Sell
29,284
-5,654
-16% -$3.19M 0.82% 38
2022
Q4
$19.2M Buy
34,938
+3,880
+12% +$2.06M 0.99% 31
2022
Q3
$15.8M Buy
31,058
+1,638
+6% +$917K 0.87% 39
2022
Q2
$16M Buy
29,420
+4,187
+17% +$2.3M 0.83% 41
2022
Q1
$14.9M Buy
25,233
+662
+3% +$380K 0.64% 48
2021
Q4
$16.4M Buy
24,571
+12,157
+98% +$7.59M 0.64% 49
2021
Q3
$7.09M Buy
12,414
+4,829
+64% +$2.65M 0.29% 78
2021
Q2
$3.83M Buy
7,585
+377
+5% +$178K 0.15% 109
2021
Q1
$3.29M Buy
7,208
+1,157
+19% +$552K 0.14% 114
2020
Q4
$2.82M Buy
6,051
+771
+15% +$362K 0.13% 113
2020
Q3
$2.33M Buy
5,280
+405
+8% +$167K 0.12% 120
2020
Q2
$1.77M Buy
4,875
+2,500
+105% +$838K 0.1% 128
2020
Q1
$674K Buy
2,375
+840
+55% +$265K 0.05% 149
2019
Q4
$499K Hold
1,535
0.03% 173
2019
Q3
$447K Hold
1,535
0.04% 166
2019
Q2
$451K Hold
1,535
0.05% 151
2019
Q1
$420K Sell
1,535
-215
-12% -$53.5K 0.04% 161
2018
Q4
$392K Sell
1,750
-328
-16% -$77K 0.04% 176
2018
Q3
$507K Sell
2,078
-7
-0.3% -$1.61K 0.05% 160
2018
Q2
$432K Buy
2,085
+12
+0.6% +$2.55K 0.04% 170
2018
Q1
$428K Buy
2,073
+19
+0.9% +$3.99K 0.04% 168
2017
Q4
$390K Sell
2,054
-177
-8% -$33.9K 0.04% 169
2017
Q3
$422K Buy
+2,231
New +$404K 0.04% 195

Other funds holding TMO

Beacon Investment Advisory Services's TMO Position: Q2 2026 in Review

Beacon Investment Advisory Services reduced its Thermo Fisher Scientific (TMO) stake by 68% in Q2 2026, selling an estimated $362K and leaving 356 shares worth $178K. The position accounts for 0.01% of the portfolio, ranked #264.

Beacon Investment Advisory Services first reported a position in TMO in Q3 2017 and has held it in 36 quarters since. The position peaked at $25.9M in Q3 2023. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Beacon Investment Advisory Services held 356 shares of Thermo Fisher Scientific worth $178K as of Q2 2026.
  • Beacon Investment Advisory Services sold 754 Thermo Fisher Scientific shares in Q2 2026, an estimated $362K.
  • Thermo Fisher Scientific made up 0.01% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #264 holding.
  • Beacon Investment Advisory Services first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 36 quarters since.
  • Beacon Investment Advisory Services's Thermo Fisher Scientific position peaked at $25.9M in Q3 2023.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.